Received Sep 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
I was very sick; I had a 3-day flu type reaction to the 1st vaccine; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of influenza-like symptoms in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: I had a 3-day flu type reaction to the 1st vaccine) and sickness (Verbatim: I was very sick). The outcome of the influenza-like symptoms was resolved (duration 3 days) and the outcome of the sickness was not reported. It was unknown if the reporter considered the influenza-like symptoms and sickness to be related to Shingrix. It was unknown if the company considered the influenza-like symptoms and sickness to be related to Shingrix. Additional Information: GSK Receipt Date: 09-SEP-2025 Consumer reported that will not be get the 2nd vaccine.